Blueberry Therapeutics Meets Endpoints in Phase 2b Trial in Onychomycosis
13 Nov 2023 //
GLOBENEWSWIRE
Blueberry Therapeutics receives clearance from the FDA of BB2603
27 Jan 2020 //
GLOBENEWSWIRE
Blueberry Therapeutics receives clearance from the FDA to proceed BB2603
27 Jan 2020 //
BUSINESSWIRE